Clinical Trial Update: Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the effect of WF10 (TCDO) on HbA1c values in patients with diabetic foot ulcer and uncontrolled diabetes; study status complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Uncontrolled Diabetes with Foot Ulcer

Drugs mentioned

• WF10 (TCDO)

Snippet

Sponsor: Srinakharinwirot University | Conditions: Diabetic Foot Ulcer (DFU), Uncontrolled Diabetes With Foot Ulcer | Phase 2 | Status: COMPLETED